首页> 外文期刊>Molecular cytogenetics >A novel five-way translocation t(7;11;9;22;9)(q22;q13;q34;q11.2;q34) involving Ph chromosome in a patient of chronic myeloid leukemia: a case report
【24h】

A novel five-way translocation t(7;11;9;22;9)(q22;q13;q34;q11.2;q34) involving Ph chromosome in a patient of chronic myeloid leukemia: a case report

机译:慢性粒细胞白血病患者涉及Ph染色体的新型五向易位t(7; 11; 9; 22; 9)(q22; q13; q34; q11.2; q34):一例

获取原文
           

摘要

About 5-10?% of chronic myelogenous leukemia (CML) patients show variant Philadelphia (Ph) translocations. The formation mechanisms and clinical significance of variant Ph translocations remain unclear. We report a CML case with a novel five-way complex translocation. Although the result of initial G-banding was 46,XY,t(7;11;9)(q22;q13;q34),t( 9;22)(q34;q11.2), fluorescence in situ hybridization (FISH) demonstrated t(7;11;9;22; 9)(q22;q13;q34;q11.2;q34) consisting of sequential rearrangements involving five chromosomes. The patient was successfully treated by imatinib and obtained a major molecular response. To our knowledge, this is the tenth CML case with a complicated Ph translocation involving five chromosomes and the third one treated by imatinib. Good response with imatinib therapy suggested that a single-event rearrangement was involved in the chromosomal changes.
机译:约5-10%的慢性粒细胞白血病(CML)患者表现出变异的费城(Ph)易位。 Ph变位易位的形成机理和临床意义尚不清楚。我们报告了一种新型五向复杂易位的CML案例。尽管初始G带的结果是46,XY,t(7; 11; 9)(q22; q13; q34),t(9; 22)(q34; q11.2),但荧光原位杂交(FISH)证明t(7; 11; 9; 22; 9)(q22; q13; q34; q11.2; q34)由涉及五个染色体的连续重排组成。该患者通过伊马替尼成功治疗,并获得了重要的分子反应。据我们所知,这是第十例CML病例,其复杂的Ph易位涉及五个染色体,而第三例则由伊马替尼治疗。伊马替尼治疗反应良好,提示单事件重排与染色体改变有关。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号